Denmark· DK-28103810805
Mucolysin Skovbær
A acetylcysteine product containing acetylcystein, registered in Denmark by Sandoz A/S. The same ATC class is registered in 15 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Acetylcysteine is registered in 15 of 19 countries.
Countries holding a registration under ATC R05CB01 (acetylcysteine), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Acetylcysteine · ATC R05CB01
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of acetylcysteine costs, country by country.
Normalised to the WHO defined daily dose (0.5 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Acetylcysteine · price per daily dose (0.5 g)
USD · FX 28 Sept 2026
- CH Switzerland$0.47
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- ACETYLCYSTEIN
- Manufacturer
- Sandoz A/S
- Country
- Denmark (DK)
- ATC code
- R05CB01
- ATC class
- Acetylcysteine
- Defined daily dose
- 0.5 g, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28103810805
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
314 interactions on record for acetylcysteine.
Graded by severity as the source publishes them — 5 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Acetylcysteine · interactions on record
314 records
- 5 moderate
- 2 minor
- 307 info
Most severe, free to view
- Insulin (human)A10AB01moderate
- Insulin (human)A10AC01moderate
- Insulin (human)A10AD01moderate
- Insulin (human)A10AE01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under R05CB01
Acetylcysteine, as other registers publish it.
- United KingdomA-CYS 200mg granules sachetsEnnogen Healthcare International Ltd
- United KingdomA-CYS 600mg capsulesEnnogen Healthcare International Ltd
- United KingdomA-CYS 600mg effervescent tabletsEnnogen Healthcare Ltd
- United KingdomA-CYS 600mg effervescent tabletsEnnogen Healthcare International Ltd
- United KingdomA-CYS 600mg tabletsEnnogen Healthcare International Ltd
- United KingdomAbNAC 600mg capsulesMaN Pharma Ltd
- United KingdomAbNAC 600mg tabletsMaN Pharma Ltd
- GermanyAccHexal Ag
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e56acd66-74bc-4ed6-bf31-2386d2d8e078 GET /v1/drugs/e56acd66-74bc-4ed6-bf31-2386d2d8e078?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "brusetabletter",
"source": "dkma",
"strength": "200 mg",
"auth_role": "DKMA",
"dk_drugid": "28103810805",
"substance": "ACETYLCYSTEIN",
"auth_procedure": "National",
"in_medicinpriser": true,
"registration_date_serial": "39265"
}See everything about acetylcysteine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.